COVID-19 Vaccine Hesitancy Among Adolescent and Young Adult Cancer Survivors.

Autor:	Waters AR; Cancer Control and Population Sciences Research Program, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Kepka D; Cancer Control and Population Sciences Research Program, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; University of Utah College of Nursing, Salt Lake City, UT, USA., Ramsay JM; Cancer Control and Population Sciences Research Program, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Mann K; Cancer Control and Population Sciences Research Program, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Vaca Lopez PL; Cancer Control and Population Sciences Research Program, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Anderson JS; Cancer Control and Population Sciences Research Program, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; University of Utah School of Medicine, Salt Lake City, UT, USA., Ou JY; Cancer Control and Population Sciences Research Program, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Kaddas HK; Cancer Control and Population Sciences Research Program, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Palmer A; Cancer Control and Population Sciences Research Program, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Ray N; Cancer Control and Population Sciences Research Program, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Tsukamoto T; Intermountain Healthcare, Salt Lake City, UT, USA., Fair DB; Primary Children's Hospital, Salt Lake City, UT, USA., Lewis MA; Intermountain Healthcare, Salt Lake City, UT, USA., Kirchhoff AC; Cancer Control and Population Sciences Research Program, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; University of Utah Department of Pediatrics, Salt Lake City, UT, USA., Warner EL; Arizona Cancer Center, Tucson, AZ, USA.; University of Arizona College of Nursing, Tucson, AZ, USA.
Jazyk:	angličtina
Zdroj:	JNCI cancer spectrum [JNCI Cancer Spectr] 2021 Jun 29; Vol. 5 (3), pp. Pkab049. Date of Electronic Publication: 2021 Jun 29 (Print Publication: 2021).
DOI:	10.1093/jncics/pkab049
Abstrakt:	The study objective was to identify sociodemographic and coronavirus disease 2019 (COVID-19) factors that are associated with COVID-19 vaccine hesitancy among adolescent and young adult (AYA) cancer survivors. Eligible participants were 18 years or older and were diagnosed with cancer as an AYA (ages 15-39 years) and received services through an AYA cancer program. A total of 342 participants completed a cross-sectional survey. Our primary outcome-COVID-19 vaccine hesitancy-was surveyed as a 5-point Likert scale and operationalized as a binary outcome (agree vs hesitant). A large proportion of participants reported COVID-19 vaccine hesitancy (37.1%). In the multivariable regression, female survivors (odds ratio = 1.81, 95% confidence interval = 1.10 to 2.98) and survivors with a high school education or less (odds ratio = 3.15, 95% confidence interval = 1.41 to 7.04) reported higher odds of vaccine hesitancy compared with their male or college graduate or higher counterparts. COVID-19 vaccine hesitancy persists among AYA survivors despite their recommended priority vaccination status and higher chances of severe COVID-19 outcomes. (© The Author(s) 2021. Published by Oxford University Press.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu